167 related articles for article (PubMed ID: 28045618)
21. Unusual extrahepatic metastatic sites from hepatocellular carcinoma.
Terada T; Maruo H
Int J Clin Exp Pathol; 2013; 6(5):816-20. PubMed ID: 23638212
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathologic analysis of stage II-III hepatocellular carcinoma showing early massive recurrence after liver resection.
Yamanaka J; Yamanaka N; Nakasho K; Tanaka T; Ando T; Yasui C; Kuroda N; Takata M; Maeda S; Matsushita K; Uematsu K; Okamoto E
J Gastroenterol Hepatol; 2000 Oct; 15(10):1192-8. PubMed ID: 11106101
[TBL] [Abstract][Full Text] [Related]
23. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
24. Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy: a multicenter retrospective study.
Park Y; Kim KS; Kim K; Chie EK; Kim JH; Kim JS; Kim TH; Kim DY; Jang WI; Kim MS; Koo TR; Chang AR
J Neurooncol; 2015 Nov; 125(2):377-83. PubMed ID: 26342711
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular Carcinoma with Bone Metastases: Incidence, Prognostic Significance, and Management-Single-Center Experience.
Bhatia R; Ravulapati S; Befeler A; Dombrowski J; Gadani S; Poddar N
J Gastrointest Cancer; 2017 Dec; 48(4):321-325. PubMed ID: 28891006
[TBL] [Abstract][Full Text] [Related]
26. Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection.
Yang Y; Nagano H; Ota H; Morimoto O; Nakamura M; Wada H; Noda T; Damdinsuren B; Marubashi S; Miyamoto A; Takeda Y; Dono K; Umeshita K; Nakamori S; Wakasa K; Sakon M; Monden M
Surgery; 2007 Feb; 141(2):196-202. PubMed ID: 17263976
[TBL] [Abstract][Full Text] [Related]
27. Treatment for extrahepatic metastasis of hepatocellular carcinoma following successful hepatic resection.
Aramaki M; Kawano K; Kai T; Yokoyama H; Morii Y; Sasaki A; Yoshida T; Kitano S
Hepatogastroenterology; 1999; 46(29):2931-4. PubMed ID: 10576375
[TBL] [Abstract][Full Text] [Related]
28. Pretreatment platelet count early predicts extrahepatic metastasis of human hepatoma.
Lee CH; Lin YJ; Lin CC; Yen CL; Shen CH; Chang CJ; Hsieh SY
Liver Int; 2015 Oct; 35(10):2327-36. PubMed ID: 25752212
[TBL] [Abstract][Full Text] [Related]
29. Gingival metastasis from primary hepatocellular carcinoma: a case report and literature review of 30 cases.
Hou Y; Deng W; Deng G; Hu L; Liu C; Xu L
BMC Cancer; 2019 Sep; 19(1):925. PubMed ID: 31521125
[TBL] [Abstract][Full Text] [Related]
30. Post-progression survival in patients with advanced hepatocellular carcinoma resistant to sorafenib.
Ogasawara S; Chiba T; Ooka Y; Suzuki E; Kanogawa N; Saito T; Motoyama T; Tawada A; Kanai F; Yokosuka O
Invest New Drugs; 2016 Apr; 34(2):255-60. PubMed ID: 26769245
[TBL] [Abstract][Full Text] [Related]
31. [A clinicopathological study of extrahepatic metastasis in autopsy cases of hepatocellular carcinoma with or without cirrhosis].
Morita T
Nihon Ika Daigaku Zasshi; 1990 Oct; 57(5):384-96. PubMed ID: 2174897
[TBL] [Abstract][Full Text] [Related]
32. Bone metastasis in hepatocellular carcinoma: need for reappraisal of treatment.
Attili VS; Babu KG; Lokanatha D; Bapsy PP; Ramachandra C; Rajshekar H
J Cancer Res Ther; 2008; 4(2):93-4. PubMed ID: 18688127
[TBL] [Abstract][Full Text] [Related]
33. Brain metastases from hepatocellular carcinoma: recent advances and future avenues.
Wang S; Wang A; Lin J; Xie Y; Wu L; Huang H; Bian J; Yang X; Wan X; Zhao H; Huang J
Oncotarget; 2017 Apr; 8(15):25814-25829. PubMed ID: 28445959
[TBL] [Abstract][Full Text] [Related]
34. HAX-1 promotes the migration and invasion of hepatocellular carcinoma cells through the induction of epithelial-mesenchymal transition via the NF-κB pathway.
Hu YL; Feng Y; Ma P; Wang F; Huang H; Guo YB; Li P; Mao QS; Xue WJ
Exp Cell Res; 2019 Aug; 381(1):66-76. PubMed ID: 31047882
[TBL] [Abstract][Full Text] [Related]
35. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
36. Effects of sorafenib combined with low-dose interferon therapy for advanced hepatocellular carcinoma: a pilot study.
Itokawa N; Atsukawa M; Tsubota A; Okubo T; Arai T; Nakagawa A; Kondo C; Iwakiri K
Int J Clin Oncol; 2016 Aug; 21(4):676-683. PubMed ID: 26701173
[TBL] [Abstract][Full Text] [Related]
37. Comparison of clinical outcome of hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma according to macrovascular invasion and transcatheter arterial chemoembolization refractory status.
Kodama K; Kawaoka T; Aikata H; Uchikawa S; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K
J Gastroenterol Hepatol; 2018 Oct; 33(10):1780-1786. PubMed ID: 29645345
[TBL] [Abstract][Full Text] [Related]
38. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular Carcinoma Peritoneal Metastasis: Role of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Spiliotis J; Nikolaou G; Kopanakis N; Vassiliadou D; Terra A; Efstathiou E
Gulf J Oncolog; 2017 May; 1(24):20-23. PubMed ID: 28797997
[TBL] [Abstract][Full Text] [Related]
40. Is it time to adopt external beam radiotherapy in the NCCN guidelines as a therapeutic strategy for intermediate/advanced hepatocellular carcinoma?
Jiang W; Zeng ZC
Oncology; 2013; 84 Suppl 1():69-74. PubMed ID: 23428862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]